Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exercise and Pioglitazone for HIV-Metabolic Syndromes

NCT00639457 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.

NCT NCT00639457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00639457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exercise and Pioglitazone for HIV-Metabolic Syndromes
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2005
Completion date
December 31, 2009
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aids, cardiovascular disease, hiv, hiv infections, lipodystrophy, obesity, type 2 diabetes